Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 14Terminated 8Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 197Lymphoid 17Other solid neoplasm 11Gynecologic 9Thoracic 7Tumor-Agnostic 6Genitourinary 3Dermatologic 3Other hematologic neoplasm 2CNS 2Sarcoma 1Head & Neck 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Fulvestrant 78pembrolizumab 77Carboplatin 73Capecitabine 69Trastuzumab 66Letrozole 62Cyclophosphamide 61Paclitaxel 60Specimen Handling 52pertuzumab 48Docetaxel 48abemaciclib 46ribociclib 44Anastrozole 35130-nm albumin-bound paclitaxel 35trastuzumab deruxtecan 34Magnetic Resonance Spectroscopy 34Tamoxifen 33Blood Specimen Collection 33sacituzumab govitecan 31exemestane 31Biopsy 31Gemcitabine 30Epirubicin 29palbociclib 28Surveys and Questionnaires 27Injections 27Drug Therapy 27pyrotinib 26eribulin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Oxaliplatin × Breast × Clear all
NCT07318805 2026-05-08

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Pfizer

Phase 1 Recruiting
260 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡